Article
Oncology
Christine Jane Kurian, Akshay Desai, William Rafferty, Ahmed Kamel Abou Hussein
Summary: This article describes the first documented case of Stevens-Johnson Syndrome (SJS) associated with alpelisib treatment. The patient experienced severe whole-body rash and buccal mucosa ulceration, but achieved remarkable improvement with the use of steroids. The authors emphasize the need for long-term monitoring of patients experiencing SJS side effects.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Teresa Bellon, Olga Gonzalez-Valle, Elena Sendagorta, Victoria Lerma, Javier Martinez Del Rio, Celia Martinez, Guillermo Servera, Carlos Gonzalez-Herrada, Lucia Cachafeiro, Jose A. Lorente, Rosario Cabanas, Pedro Herranz, Francisco de Abajo
Summary: This study found a positive correlation between IL-15 serum levels and the percentage of detached skin in SJS/TEN patients. Higher expression levels of IL-15 and IL-15RA genes were found in affected skin. The results suggest that the effects of IL-15 in SJS/TEN patients may be dependent on the expression of its private receptor IL-15R alpha in affected skin.
Review
Dermatology
Lindsey J. Gaghan, Margaret M. Coates, Lauren N. Crouse, Jayson Miedema, Julie E. Mervak, Carolyn M. Ziemer
Summary: This article reports a case of photodistributed SJS/TEN and highlights the similarities with other cases reported in the literature. A literature review revealed 8 previously reported cases of photodistributed SJS or TEN in healthy individuals. Most of these cases were young women who had exposure to UV radiation 24 to 72 hours prior to the onset of symptoms.
Article
Medicine, General & Internal
Soumya Pamnani, Sanket S. Bakshi, Sourya Acharya
Summary: Toxic epidermal necrolysis (TEN) is a severe disease associated with Stevens-Johnson syndrome (SJS). Adverse medication reactions, primarily caused by pharmaceutical drugs, contribute highly to the incidence rates of TEN, leading to significant skin and mucous membrane disintegration.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Review
Oncology
Min Deng, Huirong Chai, Meng Yang, Xueman Wei, Wenjun Zhang, Xuebin Wang, Juanjuan Li, Zhuo Wang, Haitao Chen
Summary: Enzalutamide is commonly prescribed for mCRPC, but can lead to Stevens-Johnson syndrome. Early recognition and appropriate supportive care, such as steroid therapy, are essential for successful management of this adverse event.
FRONTIERS IN ONCOLOGY
(2021)
Article
Dermatology
Yuma Sunaga, Natsumi Hama, Hirotaka Ochiai, Akatsuki Kokaze, Eun Seon Lee, Hideaki Watanabe, Michiko Kurosawa, Hiroaki Azukizawa, Hideo Asada, Yuko Watanabe, Yukie Yamaguchi, Michiko Aihara, Yoshiko Mizukawa, Manabu Ohyama, Riichiro Abe, Hideo Hashizume, Saeko Nakajima, Takashi Nomura, Kenji Kabashima, Mikiko Tohyama, Hayato Takahashi, Hiroki Mieno, Mayumi Ueta, Chie Sotozono, Hiroyuki Niihara, Eishin Morita, Hirohiko Sueki
Summary: This study aimed to identify risk factors for sepsis in Stevens-Johnson syndrome and toxic epidermal necrolysis patients. The study found that toxic epidermal necrolysis, diabetes, and intensive care unit admission were significant risk factors for sepsis. In addition, patients who had received systemic steroid therapy had a lower incidence of fever but a higher mortality rate.
JOURNAL OF DERMATOLOGICAL SCIENCE
(2022)
Article
Ophthalmology
Swati Singh, Sayan Basu
Summary: This study examined the ultrastructural features of the lacrimal glands in patients with severe dry eye due to SJS using transmission electron microscopy. The results showed that SJS patients exhibited alterations in nuclear chromatin, as well as loss of endoplasmic reticulum and mitochondria in the cytoplasm. These structural changes may be associated with severe dry eye in SJS patients.
Article
Medicine, General & Internal
Rannakoe J. Lehloenya
Summary: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) have high mortality rates and lack consensus on therapeutic interventions. International collaboration is needed to standardize research endpoints. The limitations of using BSA as the sole determinant of disease severity and the potential of artificial intelligence, biomarkers, and PET/CT scan are discussed.
FRONTIERS IN MEDICINE
(2022)
Review
Medicine, General & Internal
Seham Alsulami, Malak Aldahasi, Hazem M. Aljabri, Mazin Aljabri
Summary: Stevens-Johnson syndrome (SJS) usually presents with skin rash, mucositis, and conjunctivitis. Previous reports of SJS without skin manifestations mainly involved children and were often associated with Mycoplasma pneumoniae infection. We report a rare case of oral and ocular SJS without skin lesions in a healthy adult following exposure to azithromycin without mycoplasma pneumonia infection.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2023)
Letter
Dermatology
Melanie M. Miller, Sonia Kamath, Meagan Hughes, Nicole Harter, Minnelly Luu
Summary: This cohort study examines the relationship between etanercept treatment and outcomes of reactive infectious mucocutaneous eruption in hospitalized children and adolescents.
Article
Oncology
Jiashun Cao, Qiu Li, Xiuyi Zhi, Fan Yang, Weipeng Zhu, Ting Zhou, Xianning Hou, Donghong Chen
Summary: Immune checkpoint inhibitors (ICIs) have improved outcomes for cancer patients, but their adverse reactions, such as severe skin rash and myocarditis, require early recognition and high-dose corticosteroids for successful treatment. Fatal adverse events associated with ICIs can progress rapidly and involve multiple systems and organs, necessitating a deep understanding and vigilance from healthcare providers.
TRANSLATIONAL CANCER RESEARCH
(2021)
Article
Immunology
Yi-Teng Hung, Yau-Ren Chang, Hsuan-Ning Wang, Wei-Chen Lee, Chen-Fang Lee, Chun-Bing Chen
Summary: This article presents a diagnostic strategy for OLT-aGVHD and suggests effective and safe therapeutic options for severe sepsis in OLT-aGVHD.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Pharmacology & Pharmacy
Chuang-Wei Wang, Ivan Arni C. Preclaro, Wei-Hsiang Lin, Wen-Hung Chung
Summary: This mini review article summarizes the current knowledge of pharmacogenomics of severe adverse drug reactions (ADR) and discusses the potential clinical use of genetic markers in avoiding ADR.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Oncology
Xueqin Li, Guanghui Li, Diangang Chen, Linxi Su, Ru-peng Wang, Yi Zhou
Summary: Immune checkpoint inhibitors (ICIs) have been widely used in the clinical therapy, but skin-related adverse reactions, including Stevens-Johnson syndrome (SJS), are common. We reported a case of a 76-year-old male patient who developed SJS after treatment with ICIs, and skin tissue examination showed infiltration of T lymphocytes and PD-L1 expression.
FRONTIERS IN ONCOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Manabu Yoshioka, Yu Sawada, Motonobu Nakamura
Summary: With the advancement of technology, various new medications have been developed, but they can also cause adverse reactions, such as drug eruption. Early identification of severe skin adverse reactions is crucial, and various biomarkers have been found to help address this issue.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)